Sign up to create alerts for Instruments,
Economic Events and content by followed authors
Free Sign Up Already have an account? Sign In
Deli Fare
Sep 30, 2022 4:05AM ET
soon 12.4 $
0
0
Quotes
All Instrument Types
- All Instrument Types
- Indices
- Equities
- ETFs
- Funds
- Commodities
- Currencies
- Crypto
- Bonds
- Certificates
Please try another search
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
0.198
+0.021
+12.16%
Type:
Equity
Market:
United States
- Volume: 100
- Bid/Ask: 0.000 / 0.000
- Day's Range: 0.198 - 0.198
Eom Pharmaceutical Holdings
0.198
+0.021
+12.16%
- Discussions
- Recent Sentiments
- User Rankings
IMUC User Rankings
Users ranking according to the performance of their sentiments for the Eom Pharmaceutical Holdings Inc stock.
| Rank | Username | Total | Closed | Winning | Win % | Chg. % |
|---|---|---|---|---|---|---|
| 1 | Alessandro Paganin | 3 | 3 | 2 | 66.67 | +4539.82% |
| 2 | Gian Souza | 1 | 1 | 1 | 100 | +4406.67% |
| 3 | Denyaa Alhob | 1 | 1 | 1 | 100 | +3956% |
| 4 | Marlilson Moura | 1 | 1 | 1 | 100 | +2904.44% |
| 5 | jose paredes | 1 | 1 | 1 | 100 | +2797.14% |
| 6 | Kaspars Rieksts | 2 | 2 | 2 | 100 | +2698.2% |
| 7 | Attila Nagy | 1 | 1 | 1 | 100 | +2092.43% |
| 8 | Pranay Wakode | 1 | 1 | 1 | 100 | +1430.57% |
| 9 | Mathias Kristensen | 1 | 1 | 1 | 100 | +1430.57% |
| 10 | Nikunj Bhuva | 1 | 1 | 1 | 100 | +1430.57% |
| 11 | Firoz Patel | 1 | 1 | 1 | 100 | +1430.57% |
| 12 | Alex Nobili | 1 | 1 | 1 | 100 | +1430.57% |
| 13 | Giovanni Di Giacomo | 1 | 1 | 1 | 100 | +1430.57% |
| 14 | Abdelwaheb mejri | 1 | 1 | 1 | 100 | +1430.57% |
| 15 | João Silvestre | 1 | 1 | 1 | 100 | +1430.57% |
| 16 | Dan Nguyen | 2 | 2 | 1 | 50 | +1413.33% |
| 17 | Ahmed Tabsoba | 1 | 1 | 1 | 100 | +1298.62% |
| 18 | Nilesh Patel | 1 | 1 | 1 | 100 | +1252% |
| 19 | Arnauld Knapen | 1 | 1 | 1 | 100 | +252.7% |
| 20 | Danny Campbell | 1 | 1 | 1 | 100 | +251.17% |
| 21 | Hasan Alajlani | 1 | 1 | 1 | 100 | +239.41% |
| 22 | אלחנן מלול | 3 | 3 | 1 | 33.33 | +235.59% |
| 23 | Luca Della Rosa | 1 | 1 | 1 | 100 | +36.11% |
| 24 | gianni migno | 1 | 1 | 1 | 100 | +31.49% |
| 25 | Ganesh Selvam | 1 | 1 | 1 | 100 | +25.53% |
| 26 | VanRong Ho | 1 | 1 | 1 | 100 | +23.13% |
| 27 | Johannes Hegerl | 1 | 1 | 1 | 100 | +18.77% |
| 28 | Alfonso Araneo | 2 | 2 | 1 | 50 | +18% |
| 29 | rodelio reposar | 1 | 1 | 1 | 100 | +17.86% |
| 30 | vittorio marinello | 3 | 3 | 1 | 33.33 | +17.77% |
| 31 | alle ferro | 2 | 2 | 1 | 50 | +16.48% |
| 32 | Carlos Ingegneri | 2 | 2 | 2 | 100 | +16.05% |
| 33 | jorge gonzalez | 1 | 1 | 1 | 100 | +15.35% |
| 34 | 3 | 3 | 3 | 100 | +15.35% | |
| 35 | vbg99 | 1 | 1 | 1 | 100 | +14.8% |
| 36 | David Dugan | 1 | 1 | 1 | 100 | +10.51% |
| 37 | Jessica Wilson | 1 | 1 | 1 | 100 | +9.45% |
| 38 | Robin Shamim | 1 | 1 | 1 | 100 | +8.7% |
| 39 | Jeremy TerHaar | 1 | 1 | 1 | 100 | +8.54% |
| 40 | Nikoletta Potoczki | 1 | 1 | 1 | 100 | +7.69% |
| 41 | ricky travassos | 1 | 1 | 1 | 100 | +7.06% |
| 42 | Igor Fedoseev | 1 | 1 | 1 | 100 | +5.16% |
| 43 | Hip Hop | 1 | 1 | 1 | 100 | +4.17% |
| 44 | Martina frias terres | 1 | 1 | 1 | 100 | +3.7% |
| 45 | Ryan Miller | 1 | 1 | 1 | 100 | +0.61% |
| 46 | roberto limatola | 1 | 1 | 0 | 0 | 0% |
| 47 | Kons | 1 | 1 | 0 | 0 | -1.56% |
| 48 | manlio zuliani | 1 | 1 | 0 | 0 | -2.26% |
| 49 | Kostas Masselis | 1 | 1 | 0 | 0 | -2.38% |
| 50 | Juan Pastor | 1 | 1 | 0 | 0 | -2.72% |
Write your thoughts about Eom Pharmaceutical Holdings Inc
Are you sure you want to delete this chart?
Delete Cancel
Replace the attached chart with a new chart ?
Replace Cancel
Comment Guidelines
Deli Fare
Jun 06, 2018 3:37PM ET
Good News. Soon.
0
0
Bill Matt
Jun 06, 2018 3:37PM ET
Would you like to embellish on that
1
0
Deli Fare
May 31, 2018 1:21PM ET
Celgene buy Imuc
0
0
Deli Fare
Apr 17, 2018 9:07AM ET
Strong Buy.
0
0
Shane Coburn
Dec 21, 2017 10:54PM ET
A lot going on with this stock. class action lawsuit, prior CEO paid a company to promote or pump the stock. Turns out Immunocellular is asking the court for dismissal. We shall see... if dismissal. I'm all in, if the news is true and they have what they say they have then maybe to the moon with this one. Maybe, prior CEO didn't know what he was doing and the company was clueless, not many employees here. Also, what's going on with the clinical trials that are still on going, we know ICT-107 have been put on hold? However, No mention of Clinical Trial stage 1 ICT-121, more milestones over 18 months could this be the result of the recent new. Hush is the word here! $.29 is nothing for a stock if they play their cards right here.
1
0
dongmin ma
Dec 14, 2017 1:35PM ET
should i but this ?
0
0
NicoReggae otr
Dec 14, 2017 1:35PM ET
Don’t buy penny stocks
0
0
Add Chart to Comment
Confirm Block
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
Report this comment
I feel that this comment is:
Comment flagged
Thank You!
Your report has been sent to our moderators for review